Lead time bias in screening
Lead time bias is the false appearance of longer survival (the time from diagnosis to death) when screening brings the time of diagnosis forward.
Remember
When earlier diagnosis starts the survival clock sooner without delaying death, survival from diagnosis can look longer with no real gain. Judge a screening programme by mortality, not by survival from diagnosis.
Memory aid
Lead time gives a head start to the survival clock but not to the person.
It reminds you that earlier diagnosis starts the survival clock sooner, but if the course of the disease is unchanged the person dies at the same age.
Survival is usually counted from the date of diagnosis, giving the interval from diagnosis to death. Screening can find a disease earlier than it would have been found from symptoms. The gap between the two is the lead time, a head start for the survival clock but not for the person.
If treatment does not change when the patient dies, the interval from diagnosis to death is still longer, because the clock started sooner, even though nothing has improved for them. This false appearance of longer survival is lead time bias. In screening, a bias is a distortion in how results are interpreted.
Take a patient who dies at 70. Screening at 65 makes survival look like 5 years. Diagnosis from symptoms at 68 would make it look like 2 years. The patient lived exactly as long in both cases.
A fairer comparison counts deaths over the same period. Mortality (the number of deaths from the disease in a population over a period) is not inflated by earlier diagnosis. When survival from diagnosis is longer but mortality is unchanged, suspect lead time bias rather than a true benefit of screening.
Lead time bias is one of three biases to know in screening. With length time bias, slowly progressing disease is picked up more often by screening. With selection bias, people who attend screening differ from those who do not. Both concern which cases are found or who takes part, whereas lead time bias concerns the starting point of the clock.
Key facts
- Mechanism
- the survival clock starts earlier but death happens at the same time.
- Lead time
- the period between detecting a disease by screening and the point at which it would have been diagnosed from symptoms.
- Example
- with death at 70, diagnosis at 65 looks like 5 years of survival, whereas diagnosis at 68 looks like 2 years.
- Clue
- survival from diagnosis is longer but mortality is unchanged.
- Fairer measure
- compare deaths over the same period, not survival from diagnosis.
- Screening tests
- they are only indicative, not diagnostic, so a positive result suggests that disease may be present and needs confirming.
Exam traps
- Length time bias does not explain survival looking longer simply because the same disease was diagnosed earlier, because screening picks up slowly progressing disease more often, so it concerns which cases are found.
- Selection bias does not account for a longer interval from diagnosis when the date of death is unchanged, because it concerns people who attend screening differing from those who do not, often by being more health-conscious, which is about who takes part.
- Detection of harmless, slower-growing disease flatters survival figures too, but it does not explain the unchanged age at death of patients who do die of the cancer.
Read the full notes
Tested in 7 SimpleMed+ questions
Practice it in Population and Social Science, with the answer and a full explanation after every question.
Practice these questions